Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Arcellx Inc (ACLX)

Arcellx Inc (ACLX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 3,816,318
  • Shares Outstanding, K 57,823
  • Annual Sales, $ 107,940 K
  • Annual Income, $ -107,350 K
  • EBIT $ -243 M
  • EBITDA $ -253 M
  • 60-Month Beta 0.34
  • Price/Sales 35.09
  • Price/Cash Flow N/A
  • Price/Book 8.24

Options Overview Details

View History
  • Implied Volatility 48.76% (-1.05%)
  • Historical Volatility 67.11%
  • IV Percentile 27%
  • IV Rank 21.45%
  • IV High 85.06% on 05/14/25
  • IV Low 38.85% on 08/15/25
  • Expected Move (DTE 21) 4.29 (6.52%)
  • Put/Call Vol Ratio 0.00
  • Today's Volume 52
  • Volume Avg (30-Day) 338
  • Put/Call OI Ratio 1.41
  • Today's Open Interest 5,075
  • Open Int (30-Day) 4,916
  • Expected Range 61.51 to 70.09

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 22 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/25
See More
  • Average Estimate -1.01
  • Number of Estimates 9
  • High Estimate -0.69
  • Low Estimate -1.19
  • Prior Year -0.87
  • Growth Rate Est. (year over year) -16.09%

Price Performance

See More
Period Period Low Period High Performance
1-Month
63.48 +3.67%
on 12/19/25
79.75 -17.48%
on 12/08/25
-7.44 (-10.16%)
since 11/26/25
3-Month
63.48 +3.67%
on 12/19/25
94.07 -30.04%
on 10/16/25
-13.94 (-17.48%)
since 09/26/25
52-Week
47.86 +37.50%
on 05/07/25
94.07 -30.04%
on 10/16/25
-13.21 (-16.72%)
since 12/26/24

Most Recent Stories

More News
Arcellx Announces New Positive Data for Its iMMagine-1 Study in Patients with Relapsed and/or Refractory Multiple Myeloma

-- Anito-cel demonstrated 96% ORR and 74% CR/sCR at a median follow-up of 15.9 months; responses continue to deepen over time -- -- Overall MRD negativity was...

ACLX : 65.71 (-0.44%)
Arcellx to Host Investor Relations Event During the 67th ASH Annual Meeting and Exposition

Saturday, December 6, 2025 at 8:00 p.m. ET

ACLX : 65.71 (-0.44%)
Arcellx Provides Third Quarter 2025 Financial Results

 

ACLX : 65.71 (-0.44%)
Arcellx to Present New Data for Its iMMagine-1 Study and Continues Scientific Momentum with Multiple Presentations at the 67th ASH Annual Meeting and Exposition

-- A more recent data cut will be shared during an oral presentation for the iMMagine-1 study -- -- To date, no delayed neurotoxicities, including no Parkinsonism, no...

ACLX : 65.71 (-0.44%)
Arcellx Inc (ACLX) Has a New Rating from Stifel Nicolaus

Arcellx Inc received a Buy rating and a $129.00 price target from Stifel Nicolaus analyst Stephen Willey today. The company’s shares closed yesterday at $92.37.Elevate Your Investing Strategy: Take advantage...

ACLX : 65.71 (-0.44%)
Canaccord Genuity Keeps Their Buy Rating on Arcellx Inc (ACLX)

Canaccord Genuity analyst John Newman maintained a Buy rating on Arcellx Inc today and set a price target of $121.00. The company’s shares closed yesterday at $87.33.Elevate Your Investing Strategy:...

ACLX : 65.71 (-0.44%)
Arcellx Inc (ACLX) Receives a Hold from Cantor Fitzgerald

In a report released today, Eric Schmidt FCA from Cantor Fitzgerald maintained a Hold rating on Arcellx Inc. The company’s shares closed yesterday at $88.29.Elevate Your Investing Strategy: Take advantage...

ACLX : 65.71 (-0.44%)
Bank of America Securities Keeps Their Buy Rating on Arcellx Inc (ACLX)

Bank of America Securities analyst Jason Gerberry maintained a Buy rating on Arcellx Inc today and set a price target of $112.00. The company’s shares closed yesterday at $82.24.Elevate Your Investing...

ACLX : 65.71 (-0.44%)
Arcellx to Participate at the 2025 Morgan Stanley Global Healthcare Conference

Arcellx, Inc. (NASDAQ: ACLX), a biotechnology company reimagining cell therapy through the development of innovative immunotherapies for patients with cancer and other incurable diseases, today announced...

ACLX : 65.71 (-0.44%)
Arcellx Provides Second Quarter 2025 Financial Results and Business Highlights

-- Presented preliminary data from a May 1, 2025 data cutoff date for all 117 patients with a median follow-up of 12.6 months in the Phase 2 pivotal iMMagine-1 study of...

ACLX : 65.71 (-0.44%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Sell with a Weakening short term outlook on maintaining the current direction.

See More Share

Business Summary

Arcellx Inc. is a biotechnology company reimagining cell therapy through the development of innovative immunotherapies for patients with cancer and other incurable diseases. Arcellx Inc. is based in GAITHERSBURG, Md.

See More

Key Turning Points

3rd Resistance Point 67.60
2nd Resistance Point 67.20
1st Resistance Point 66.60
Last Price 65.71
1st Support Level 65.59
2nd Support Level 65.19
3rd Support Level 64.59

See More

52-Week High 94.07
Fibonacci 61.8% 76.42
Fibonacci 50% 70.97
Last Price 65.71
Fibonacci 38.2% 65.51
52-Week Low 47.86

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar